Therapy News and Research

RSS

New drug Aliskiren shows promise for heart failure patients

A study published in the International Journal of Molecular Sciences, as part of a special issue “Heart Failure: From Molecular Basis to Therapy”, in August 2019, shows that aliskiren, a drug approved by the US Food and Drug Administration (FDA), can improve survival for over 5 years, on average, and enhance life quality in patients who have been correctly diagnosed with heart failure.

9 Oct 2019

Study: The effect of electrical stimulation therapies on spinal fusion

Researchers from The Johns Hopkins University School of Medicine performed a systematic review and meta-analysis of published data on the effect of electrical stimulation therapies on spinal fusion.

9 Oct 2019

Hormone therapy worsens quality of life in women with breast cancer

Analysis of the CANTO cohort published in the journal Annals of Oncology will upset received wisdom on the effects that hormone therapy and chemotherapy have on the quality of life in women with breast cancer. Contrary to the commonly held view, 2 years after diagnosis, hormone therapy, a highly effective breast cancer treatment worsens quality of life to a greater extent and for a longer time, especially in menopausal patients.

8 Oct 2019

Combination treatment cures pancreatic cancer, reprograms the immune system

A University of Rochester Wilmot Cancer Institute research team reports that combining a type of radiation therapy with immunotherapy not only cures pancreatic cancer in mice, but appears to reprogram the immune system to create an "immune memory" in the same way that a vaccine keeps the flu away.

8 Oct 2019

Aliskiren drug can delay progression of congestive heart failure, lengthen survival rates

Researchers at the University of Arizona College of Medicine - Phoenix have shown for the first time in preclinical studies that Aliskiren, a drug that inhibits the enzyme that regulates blood pressure, can delay the progression of congestive heart failure and lengthen survival rates.

8 Oct 2019

Differences at the single-cell level can predict responses to BRAF inhibitor therapy

Patients with advanced melanoma have been able to live longer because of several newly approved targeted treatment options, including BRAF and MEK inhibitors. However, patients will often have different responses to the same treatment due to genetic variability.

8 Oct 2019

New understanding of breast cancer metastasis to bone

In breast cancer patients with metastatic disease, bone is the most common site of metastasis and the most common site of first distant relapse, with roughly half (48%) of breast cancer patients developing bone metastases after treatment.

8 Oct 2019

UTHealth: Psychedelic drug being studied to relieve treatment-resistant depression

Psilocybin, a psychedelic drug believed to help rewire the brain, is now being studied to relieve treatment-resistant depression at The University of Texas Health Science Center at Houston (UTHealth) as part of a global Phase II clinical trial.

8 Oct 2019

New experimental growth factor drug appears to prevent worsening of osteoarthritis

More than 10 percent of Americans over age 60 experience knee pain related to osteoarthritis, the most common disease of the knee joint. Osteoarthritis of the knee causes pain, activity limitation, physical disability, reduced health-related quality of life and excess mortality compared with the general population.

8 Oct 2019

Maternal stress could affect a baby's brain development

New research from King's College London has found that maternal stress before and during pregnancy could affect a baby's brain development.

8 Oct 2019

Study receives NCI grant to explore better treatment for brain tumors in children

Children with recurrent brain tumors or newly diagnosed, particularly aggressive tumors called diffuse intrinsic pontine gliomas are being enrolled in the first study to examine the efficacy of a drug that inhibits an enzyme these tumors use to protect themselves from the child's natural immune response.

8 Oct 2019

Ground-breaking online tool launched to help people maintain good mental health

A groundbreaking online tool has been launched to help people gain better control over their mental health.

8 Oct 2019

Study: UNAIDS HIV targets will be missed among men who have sex with men in Africa

Despite improvements in HIV testing among men who have sex with men (MSM) in Africa, many are missing out on HIV treatment.

8 Oct 2019

UVA researchers uncover key contributor to multiple sclerosis

Cells that scientists have largely ignored when studying multiple sclerosis are actually key contributors to MS development, new research from the University of Virginia School of Medicine shows.

8 Oct 2019

New insight into meningioma - possibility of targeted therapy

A new study published in the journal Oncotarget shows that certain mutations in the brain tumor called meningioma may help identify patients who have a better chance of recovery. This could help physicians make better clinical decisions based on more accurate diagnoses. It has also unveiled some of the genes that go wrong in meningiomas, as well as showing how targeted therapy could one day help fight this tumor.

7 Oct 2019

Therapy News and Research

New drug Aliskiren shows promise for heart failure patients

Study: The effect of electrical stimulation therapies on spinal fusion

Hormone therapy worsens quality of life in women with breast cancer

Combination treatment cures pancreatic cancer, reprograms the immune system

Aliskiren drug can delay progression of congestive heart failure, lengthen survival rates

Differences at the single-cell level can predict responses to BRAF inhibitor therapy

New understanding of breast cancer metastasis to bone

UTHealth: Psychedelic drug being studied to relieve treatment-resistant depression

New experimental growth factor drug appears to prevent worsening of osteoarthritis

Maternal stress could affect a baby's brain development

Study receives NCI grant to explore better treatment for brain tumors in children

Ground-breaking online tool launched to help people maintain good mental health

Study: UNAIDS HIV targets will be missed among men who have sex with men in Africa

UVA researchers uncover key contributor to multiple sclerosis

New insight into meningioma - possibility of targeted therapy

Carnegie Mellon and Yale win NIH grant to advance gene editing technique

Researchers study how allergens get on our nerves to drive inflammation in atopic dermatitis

Study identifies genetic marker which could personalize treatment for Crohn's disease

Osaka University Hospital begins clinical research for prostate cancer diagnosis using PET imaging

New device can accelerate bone regeneration in difficult cases

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News